Replies to post #350205 on NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

The 8-K mentions the German tax issue, but only in the sense that there is no issue with Marcum about it.

We'll never know what prompted the Audit Committee to perform a review of the auditor and recommend a change. The only thing the 8-K mentions is fees.

Maybe next year someone will remember to compare the CB fees to the earlier Marcum fees.